As I said to my broker at credit swuisse, this new analyst came out with coverage on large pharma and I think except for Gilead gave all the companies a neutral.
I think it is moronic for a new analyst to come out with neutral ratings basically telling clients not to buy or sell. If his picks aren't buys he should look for new stocks.